Show Eula
  •  

  •  

  •  

  • Quick Tour
  • My CME
  • My Folder
  • Login
inPractice
  • Specialty
  • Decision Tools
  • Drug Reference
  • Guidelines
  • PubMed
  • More
    • Trials
    • Conference Data
    • Suggested CME

About Tools

Our interactive decision support tools use algorithms to provide recommendations based on your input of case-specific information

  • Jointly Provided by USF Health and Clinical Care Options, LLC

    • USF

      More information about our provider

  • inPractice® is supported by educational grants from:

    • Gilead
      (inPractice Hepatology)
    • Gilead
      (inPractice HIV)
    • Janssen
      (inPractice HIV)
    • Viiv
      (inPractice HIV)
    • Viiv
      (inPractice HIV)
    • Novartis Pharmaceuticals
      (inPractice Oncology)
    • Taiho Pharmaceuticals
      (inPractice Oncology)
    • AstraZeneca
      (inPractice Breast Cancer)
    • Bayer Pharmaceuticals
      (inPractice Gastrointestinal Cancer)
    • AstraZeneca
      (inPractice Gynecologic Cancer)
    • AstraZeneca
      (inPractice Lung Cancer)
    • AbbVie
      (inPractice Oncology Nursing)
    • Amgen
      (inPractice Oncology Nursing)
    • AstraZeneca
      (inPractice Oncology Nursing)
    • BMS
      (inPractice Oncology Nursing)
    • Celgene
      (inPractice Oncology Nursing)
    • Daiichi
      (inPractice Oncology Nursing)
    • Jazz Pharmaceuticals
      (inPractice Oncology Nursing)
    • Lilly
      (inPractice Oncology Nursing)
    • Novartis Pharmaceuticals
      (inPractice Oncology Nursing)

    full listing of commercial supporters

Tools

Decision Algorithms & Expert Insight Tools

  • Oncology

    • Advanced Bladder Cancer Treatment: Patient-Specific Expert Insights and Strategies
    • Expert Guidance on Selecting Treatment for Metastatic Breast Cancer
    • Early Breast Cancer: Expert Guidance on Neoadjuvant and Adjuvant Therapy
    • Expert Guidance on Choice of Bone-Targeted Therapy for Patients With Breast Cancer
    • Focus on Metastatic Colorectal Cancer: An Interactive Decision Support Tool
    • Advanced Renal Cell Carcinoma: Patient-Specific Recommendations From an International Panel of Experts
    • Expert Guidance on Choice of Bone-Targeted Therapy for Patients With Prostate Cancer
    • Myelofibrosis and Polycythemia Vera: Expert Guidance for Treatment Selection
    • Expert Insight for the Selection of Induction, Maintenance, and Relapsed/Refractory Therapy for Multiple Myeloma
    • Chronic Lymphocytic Leukemia: Expert Guidance for Treatment Selection
    • Chronic Myeloid Leukemia: Expert Guidance on Monitoring Response to First-line Tyrosine Kinase Inhibitor Therapy
    • Critical Decisions in Mantle Cell Lymphoma: An Integrated Educational Approach With Decision Support
    • Managing Immune-Related Adverse Events: An Interactive Algorithm Tool
    • Advanced NSCLC: Expert Insight on the Selection of First-line and Second-line Therapy—2017.2
    • Expert Guidance on Selecting Therapy for Advanced Melanoma

inPractice

  • Home
  • About inPractice®
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • CME Info
  • Site Requirements

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Tracking Information